{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:59:42Z","timestamp":1790395182417,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.4158\/ep12139.ra","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T21:05:13Z","timestamp":1349816713000},"page":"763-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Syndromic Insulin Resistance: Models for the Therapeutic Basis of the Metabolic Syndrome and Other Targets of Insulin Resistance"],"prefix":"10.1016","volume":"18","author":[{"given":"Phillip","family":"Gorden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elika Safar","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12139.RA_bb0010","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"10.4158\/EP12139.RA_bb0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2105\/AJPH.89.8.1194","article-title":"The direct health care costs of obesity in the United States","volume":"89","author":"Allison","year":"1999","journal-title":"Am J Public Health"},{"key":"10.4158\/EP12139.RA_bb0020","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1210\/jc.2004-0535","article-title":"Medical consequences of obesity","volume":"89","author":"Bray","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0025","first-page":"1","article-title":"Prevalence of obesity in the United States, 2009-2010","volume":"82","author":"Ogden","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.4158\/EP12139.RA_bb0030","series-title":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"10.4158\/EP12139.RA_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archpedi.160.5.523","article-title":"Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002","volume":"160","author":"Duncan","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.4158\/EP12139.RA_bb0040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1998","journal-title":"Diabetes"},{"key":"10.4158\/EP12139.RA_bb0045","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.4158\/EP12139.RA_bb0050","doi-asserted-by":"crossref","unstructured":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.4158\/EP12139.RA_bb0055","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11892-005-0001-8","article-title":"The impact of evidence-based medicine on diabetes therapy","volume":"5","author":"Gorden","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.4158\/EP12139.RA_bb0065","first-page":"854","article-title":"UK Prospective Diabetes Study (UKPDS) Group [Erratum in Lancet. 1998;352:158]","volume":"352","author":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","year":"1998","journal-title":"Lancet"},{"key":"10.4158\/EP12139.RA_bb0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.4158\/EP12139.RA_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue [Erratum in: Nature. 1995;374: 479]","volume":"372","author":"Zhang","year":"1995","journal-title":"Nature"},{"key":"10.4158\/EP12139.RA_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0085","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.4158\/EP12139.RA_bb0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12139.RA_bb0100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0105","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"10.4158\/EP12139.RA_bb0115","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes","volume":"50","author":"Ebihara","year":"2001","journal-title":"Diabetes"},{"key":"10.4158\/EP12139.RA_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","article-title":"Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy","volume":"53","author":"Moran","year":"2004","journal-title":"Metabolism"},{"key":"10.4158\/EP12139.RA_bb0125","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12139.RA_bb0130","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"key":"10.4158\/EP12139.RA_bb0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy","volume":"56","author":"Park","year":"2007","journal-title":"Metabolism"},{"key":"10.4158\/EP12139.RA_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"10.4158\/EP12139.RA_bb0145","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12139.RA_bb0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","volume":"41","author":"Javor","year":"2005","journal-title":"Hepatology"},{"key":"10.4158\/EP12139.RA_bb0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12139.RA_bb0170","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","article-title":"Clinical effects of long-term metreleptin treatment in patients with lipodystrophy","volume":"17","author":"Chan","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12139.RA_bb0175","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00125-010-1719-7","article-title":"Is there a human model for the \u2018metabolic syndrome\u2019 with a defined aetiology?","volume":"53","author":"Gorden","year":"2010","journal-title":"Diabetologia"},{"key":"10.4158\/EP12139.RA_bb0180","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI108565","article-title":"Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting","volume":"58","author":"Bar","year":"1976","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12139.RA_bb0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.4158\/EP12139.RA_bb0190","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"10.4158\/EP12139.RA_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab"},{"key":"10.4158\/EP12139.RA_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diab.45.4.531","article-title":"Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob\/ob mice","volume":"45","author":"Schwartz","year":"1996","journal-title":"Diabetes"},{"key":"10.4158\/EP12139.RA_bb0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.01-0164com","article-title":"Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats","volume":"16","author":"Hidaka","year":"2002","journal-title":"FASEB J"},{"key":"10.4158\/EP12139.RA_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP12139.RA_bb0215","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1464-5491.2005.01529.x","article-title":"Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus","volume":"22","author":"Coll","year":"2005","journal-title":"Diabet Med"},{"key":"10.4158\/EP12139.RA_bb0220","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","article-title":"Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies","volume":"95","author":"Malek","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0225","series-title":"Insulin Resistance.","first-page":"123","article-title":"Autoimmune mechanisms of insulin resistance and hypoglycemia","author":"Gorden","year":"1993"},{"key":"10.4158\/EP12139.RA_bb0230","first-page":"1242","article-title":"Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients","volume":"74","author":"Sluss","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1210\/jc.2008-1749","article-title":"Anti-melanocortin-4 receptor autoantibodies in obesity","volume":"94","author":"Peter","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0240","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(78)92099-8","article-title":"Autoantibodies to parathyroid hormone receptor","volume":"2","author":"Juppner","year":"1978","journal-title":"Lancet"},{"key":"10.4158\/EP12139.RA_bb0245","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0889-8529(18)30392-X","article-title":"Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor","volume":"18","author":"Taylor","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP12139.RA_bb0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MD.0b013e3181a5b42e","article-title":"Autoimmune forms of hypoglycemia","volume":"88","author":"Lupsa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP12139.RA_bb0260","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2003-031952","article-title":"Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome","volume":"89","author":"Cochran","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP12139.RA_bb0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.2009-0543","article-title":"Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance","volume":"95","author":"Skarulis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0275","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2010.02.001","article-title":"Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat","volume":"11","author":"Hondares","year":"2010","journal-title":"Cell Metab"},{"key":"10.4158\/EP12139.RA_bb0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev"},{"key":"10.4158\/EP12139.RA_bb0285","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12139.RA_bb0290","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.4158\/EP12139.RA_bb0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"10.4158\/EP12139.RA_bb0300","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0305","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.4158\/EP12139.RA_bb0310","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"key":"10.4158\/EP12139.RA_bb0315","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12139.RA_bb0320","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI46405","article-title":"Mitochondrial dysfunction in patients with primary congenital insulin resistance","volume":"121","author":"Sleigh","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/N5614VQ320067P74.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:42Z","timestamp":1761515622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20429222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1530891X20429222"],"URL":"https:\/\/doi.org\/10.4158\/ep12139.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndromic Insulin Resistance: Models for the Therapeutic Basis of the Metabolic Syndrome and Other Targets of Insulin Resistance","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12139.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}